世界のモノクローナル抗体滅菌注射薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Monoclonal Antibodies Sterile Injectable Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-105X12001
• 出版社/出版日： / 2021年5月
• レポート形態：英文、PDF、102ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料では、モノクローナル抗体滅菌注射薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。モノクローナル抗体滅菌注射薬の種類別市場規模（In Vivo生産薬、In Vitro生産薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・モノクローナル抗体滅菌注射薬の市場概要
・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、Pfizer、Abbott、GlaxoSmithKline、AstraZeneca、Novartis、Bayer、Amgen、Bristol Myers Squibb、Johnson&Johnson、Roche、Sanofi
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：In Vivo生産薬、In Vitro生産薬
・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局
・モノクローナル抗体滅菌注射薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・モノクローナル抗体滅菌注射薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・モノクローナル抗体滅菌注射薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・モノクローナル抗体滅菌注射薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン
・モノクローナル抗体滅菌注射薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Monoclonal Antibodies Sterile Injectable Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Monoclonal Antibodies Sterile Injectable Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Monoclonal Antibodies Sterile Injectable Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Monoclonal Antibodies Sterile Injectable Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
In Vivo Production Drugs
In Vitro Production Drugs

Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

The key market players for global Monoclonal Antibodies Sterile Injectable Drugs market are listed below:
Merck
Pfizer
Abbott
GlaxoSmithKline
AstraZeneca
Novartis
Bayer
Amgen
Bristol Myers Squibb
Johnson&Johnson
Roche
Sanofi

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Monoclonal Antibodies Sterile Injectable Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Monoclonal Antibodies Sterile Injectable Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 In Vivo Production Drugs
1.2.3 In Vitro Production Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Monoclonal Antibodies Sterile Injectable Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Monoclonal Antibodies Sterile Injectable Drugs Market Size & Forecast
1.4.1 Global Monoclonal Antibodies Sterile Injectable Drugs Sales in Value (2016-2026))
1.4.2 Global Monoclonal Antibodies Sterile Injectable Drugs Sales in Volume (2016-2026)
1.4.3 Global Monoclonal Antibodies Sterile Injectable Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Monoclonal Antibodies Sterile Injectable Drugs Production Capacity Analysis
1.5.1 Global Monoclonal Antibodies Sterile Injectable Drugs Total Production Capacity (2016-2026)
1.5.2 Global Monoclonal Antibodies Sterile Injectable Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Monoclonal Antibodies Sterile Injectable Drugs Market Drivers
1.6.2 Monoclonal Antibodies Sterile Injectable Drugs Market Restraints
1.6.3 Monoclonal Antibodies Sterile Injectable Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Monoclonal Antibodies Sterile Injectable Drugs Product and Services
2.1.4 Merck Monoclonal Antibodies Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Monoclonal Antibodies Sterile Injectable Drugs Product and Services
2.2.4 Pfizer Monoclonal Antibodies Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Monoclonal Antibodies Sterile Injectable Drugs Product and Services
2.3.4 Abbott Monoclonal Antibodies Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Monoclonal Antibodies Sterile Injectable Drugs Product and Services
2.4.4 GlaxoSmithKline Monoclonal Antibodies Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Monoclonal Antibodies Sterile Injectable Drugs Product and Services
2.5.4 AstraZeneca Monoclonal Antibodies Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Monoclonal Antibodies Sterile Injectable Drugs Product and Services
2.6.4 Novartis Monoclonal Antibodies Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Bayer
2.7.1 Bayer Details
2.7.2 Bayer Major Business
2.7.3 Bayer Monoclonal Antibodies Sterile Injectable Drugs Product and Services
2.7.4 Bayer Monoclonal Antibodies Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business
2.8.3 Amgen Monoclonal Antibodies Sterile Injectable Drugs Product and Services
2.8.4 Amgen Monoclonal Antibodies Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Bristol Myers Squibb
2.9.1 Bristol Myers Squibb Details
2.9.2 Bristol Myers Squibb Major Business
2.9.3 Bristol Myers Squibb Monoclonal Antibodies Sterile Injectable Drugs Product and Services
2.9.4 Bristol Myers Squibb Monoclonal Antibodies Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Johnson&Johnson
2.10.1 Johnson&Johnson Details
2.10.2 Johnson&Johnson Major Business
2.10.3 Johnson&Johnson Monoclonal Antibodies Sterile Injectable Drugs Product and Services
2.10.4 Johnson&Johnson Monoclonal Antibodies Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Roche
2.11.1 Roche Details
2.11.2 Roche Major Business
2.11.3 Roche Monoclonal Antibodies Sterile Injectable Drugs Product and Services
2.11.4 Roche Monoclonal Antibodies Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Sanofi
2.12.1 Sanofi Details
2.12.2 Sanofi Major Business
2.12.3 Sanofi Monoclonal Antibodies Sterile Injectable Drugs Product and Services
2.12.4 Sanofi Monoclonal Antibodies Sterile Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Monoclonal Antibodies Sterile Injectable Drugs Sales by Manufacturer
3.1 Global Monoclonal Antibodies Sterile Injectable Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Monoclonal Antibodies Sterile Injectable Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Monoclonal Antibodies Sterile Injectable Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Monoclonal Antibodies Sterile Injectable Drugs Manufacturer Market Share
3.4.2 Top 6 Monoclonal Antibodies Sterile Injectable Drugs Manufacturer Market Share
3.5 Global Monoclonal Antibodies Sterile Injectable Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Monoclonal Antibodies Sterile Injectable Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Monoclonal Antibodies Sterile Injectable Drugs Market Size by Region
4.1.1 Global Monoclonal Antibodies Sterile Injectable Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Monoclonal Antibodies Sterile Injectable Drugs Revenue by Region (2016-2026)
4.2 North America Monoclonal Antibodies Sterile Injectable Drugs Revenue (2016-2026)
4.3 Europe Monoclonal Antibodies Sterile Injectable Drugs Revenue (2016-2026)
4.4 Asia-Pacific Monoclonal Antibodies Sterile Injectable Drugs Revenue (2016-2026)
4.5 South America Monoclonal Antibodies Sterile Injectable Drugs Revenue (2016-2026)
4.6 Middle East and Africa Monoclonal Antibodies Sterile Injectable Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Monoclonal Antibodies Sterile Injectable Drugs Sales in Volume by Type (2016-2026)
5.2 Global Monoclonal Antibodies Sterile Injectable Drugs Revenue by Type (2016-2026)
5.3 Global Monoclonal Antibodies Sterile Injectable Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Monoclonal Antibodies Sterile Injectable Drugs Sales in Volume by Application (2016-2026)
6.2 Global Monoclonal Antibodies Sterile Injectable Drugs Revenue by Application (2016-2026)
6.3 Global Monoclonal Antibodies Sterile Injectable Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Monoclonal Antibodies Sterile Injectable Drugs Sales by Type (2016-2026)
7.2 North America Monoclonal Antibodies Sterile Injectable Drugs Sales by Application (2016-2026)
7.3 North America Monoclonal Antibodies Sterile Injectable Drugs Market Size by Country
7.3.1 North America Monoclonal Antibodies Sterile Injectable Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Monoclonal Antibodies Sterile Injectable Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Monoclonal Antibodies Sterile Injectable Drugs Sales by Type (2016-2026)
8.2 Europe Monoclonal Antibodies Sterile Injectable Drugs Sales by Application (2016-2026)
8.3 Europe Monoclonal Antibodies Sterile Injectable Drugs Market Size by Country
8.3.1 Europe Monoclonal Antibodies Sterile Injectable Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Monoclonal Antibodies Sterile Injectable Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Monoclonal Antibodies Sterile Injectable Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Monoclonal Antibodies Sterile Injectable Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Monoclonal Antibodies Sterile Injectable Drugs Market Size by Region
9.3.1 Asia-Pacific Monoclonal Antibodies Sterile Injectable Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Monoclonal Antibodies Sterile Injectable Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Monoclonal Antibodies Sterile Injectable Drugs Sales by Type (2016-2026)
10.2 South America Monoclonal Antibodies Sterile Injectable Drugs Sales by Application (2016-2026)
10.3 South America Monoclonal Antibodies Sterile Injectable Drugs Market Size by Country
10.3.1 South America Monoclonal Antibodies Sterile Injectable Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Monoclonal Antibodies Sterile Injectable Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Monoclonal Antibodies Sterile Injectable Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Monoclonal Antibodies Sterile Injectable Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Monoclonal Antibodies Sterile Injectable Drugs Market Size by Country
11.3.1 Middle East & Africa Monoclonal Antibodies Sterile Injectable Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Monoclonal Antibodies Sterile Injectable Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Monoclonal Antibodies Sterile Injectable Drugs Typical Distributors
12.3 Monoclonal Antibodies Sterile Injectable Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Monoclonal Antibodies Sterile Injectable Drugs Product and Services
Table 6. Merck Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Monoclonal Antibodies Sterile Injectable Drugs Product and Services
Table 10. Pfizer Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Abbott Basic Information, Manufacturing Base and Competitors
Table 12. Abbott Major Business
Table 13. Abbott Monoclonal Antibodies Sterile Injectable Drugs Product and Services
Table 14. Abbott Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 16. GlaxoSmithKline Major Business
Table 17. GlaxoSmithKline Monoclonal Antibodies Sterile Injectable Drugs Product and Services
Table 18. GlaxoSmithKline Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 20. AstraZeneca Major Business
Table 21. AstraZeneca Monoclonal Antibodies Sterile Injectable Drugs Product and Services
Table 22. AstraZeneca Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Monoclonal Antibodies Sterile Injectable Drugs Product and Services
Table 26. Novartis Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Bayer Basic Information, Manufacturing Base and Competitors
Table 28. Bayer Major Business
Table 29. Bayer Monoclonal Antibodies Sterile Injectable Drugs Product and Services
Table 30. Bayer Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Amgen Basic Information, Manufacturing Base and Competitors
Table 32. Amgen Major Business
Table 33. Amgen Monoclonal Antibodies Sterile Injectable Drugs Product and Services
Table 34. Amgen Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 36. Bristol Myers Squibb Major Business
Table 37. Bristol Myers Squibb Monoclonal Antibodies Sterile Injectable Drugs Product and Services
Table 38. Bristol Myers Squibb Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Johnson&Johnson Basic Information, Manufacturing Base and Competitors
Table 40. Johnson&Johnson Major Business
Table 41. Johnson&Johnson Monoclonal Antibodies Sterile Injectable Drugs Product and Services
Table 42. Johnson&Johnson Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Roche Basic Information, Manufacturing Base and Competitors
Table 44. Roche Major Business
Table 45. Roche Monoclonal Antibodies Sterile Injectable Drugs Product and Services
Table 46. Roche Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Sanofi Basic Information, Manufacturing Base and Competitors
Table 48. Sanofi Major Business
Table 49. Sanofi Monoclonal Antibodies Sterile Injectable Drugs Product and Services
Table 50. Sanofi Monoclonal Antibodies Sterile Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Monoclonal Antibodies Sterile Injectable Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 52. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Monoclonal Antibodies Sterile Injectable Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Monoclonal Antibodies Sterile Injectable Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Monoclonal Antibodies Sterile Injectable Drugs Production Site of Key Manufacturer
Table 56. Global Monoclonal Antibodies Sterile Injectable Drugs Sales by Region (2016-2021e) & (K Units)
Table 57. Global Monoclonal Antibodies Sterile Injectable Drugs Sales by Region (2021-2026) & (K Units)
Table 58. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 59. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue by Region (2021-2026) & (USD Million)
Table 60. Global Monoclonal Antibodies Sterile Injectable Drugs Sales by Type (2016-2021e) & (K Units)
Table 61. Global Monoclonal Antibodies Sterile Injectable Drugs Sales by Type (2021-2026) & (K Units)
Table 62. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 63. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue by Type (2021-2026) & (USD Million)
Table 64. Global Monoclonal Antibodies Sterile Injectable Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 65. Global Monoclonal Antibodies Sterile Injectable Drugs Price by Type (2021-2026) & (USD/Unit)
Table 66. Global Monoclonal Antibodies Sterile Injectable Drugs Sales by Application (2016-2021e) & (K Units)
Table 67. Global Monoclonal Antibodies Sterile Injectable Drugs Sales by Application (2021-2026) & (K Units)
Table 68. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 69. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue by Application (2021-2026) & (USD Million)
Table 70. Global Monoclonal Antibodies Sterile Injectable Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 71. Global Monoclonal Antibodies Sterile Injectable Drugs Price by Application (2021-2026) & (USD/Unit)
Table 72. North America Monoclonal Antibodies Sterile Injectable Drugs Sales by Country (2016-2021e) & (K Units)
Table 73. North America Monoclonal Antibodies Sterile Injectable Drugs Sales by Country (2021-2026) & (K Units)
Table 74. North America Monoclonal Antibodies Sterile Injectable Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 75. North America Monoclonal Antibodies Sterile Injectable Drugs Revenue by Country (2021-2026) & (USD Million)
Table 76. North America Monoclonal Antibodies Sterile Injectable Drugs Sales by Type (2016-2021e) & (K Units)
Table 77. North America Monoclonal Antibodies Sterile Injectable Drugs Sales by Type (2021-2026) & (K Units)
Table 78. North America Monoclonal Antibodies Sterile Injectable Drugs Sales by Application (2016-2021e) & (K Units)
Table 79. North America Monoclonal Antibodies Sterile Injectable Drugs Sales by Application (2021-2026) & (K Units)
Table 80. Europe Monoclonal Antibodies Sterile Injectable Drugs Sales by Country (2016-2021e) & (K Units)
Table 81. Europe Monoclonal Antibodies Sterile Injectable Drugs Sales by Country (2021-2026) & (K Units)
Table 82. Europe Monoclonal Antibodies Sterile Injectable Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 83. Europe Monoclonal Antibodies Sterile Injectable Drugs Revenue by Country (2021-2026) & (USD Million)
Table 84. Europe Monoclonal Antibodies Sterile Injectable Drugs Sales by Type (2016-2021e) & (K Units)
Table 85. Europe Monoclonal Antibodies Sterile Injectable Drugs Sales by Type (2021-2026) & (K Units)
Table 86. Europe Monoclonal Antibodies Sterile Injectable Drugs Sales by Application (2016-2021e) & (K Units)
Table 87. Europe Monoclonal Antibodies Sterile Injectable Drugs Sales by Application (2021-2026) & (K Units)
Table 88. Asia-Pacific Monoclonal Antibodies Sterile Injectable Drugs Sales by Region (2016-2021e) & (K Units)
Table 89. Asia-Pacific Monoclonal Antibodies Sterile Injectable Drugs Sales by Region (2021-2026) & (K Units)
Table 90. Asia-Pacific Monoclonal Antibodies Sterile Injectable Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 91. Asia-Pacific Monoclonal Antibodies Sterile Injectable Drugs Revenue by Region (2021-2026) & (USD Million)
Table 92. Asia-Pacific Monoclonal Antibodies Sterile Injectable Drugs Sales by Type (2016-2021e) & (K Units)
Table 93. Asia-Pacific Monoclonal Antibodies Sterile Injectable Drugs Sales by Type (2021-2026) & (K Units)
Table 94. Asia-Pacific Monoclonal Antibodies Sterile Injectable Drugs Sales by Application (2016-2021e) & (K Units)
Table 95. Asia-Pacific Monoclonal Antibodies Sterile Injectable Drugs Sales by Application (2021-2026) & (K Units)
Table 96. South America Monoclonal Antibodies Sterile Injectable Drugs Sales by Country (2016-2021e) & (K Units)
Table 97. South America Monoclonal Antibodies Sterile Injectable Drugs Sales by Country (2021-2026) & (K Units)
Table 98. South America Monoclonal Antibodies Sterile Injectable Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 99. South America Monoclonal Antibodies Sterile Injectable Drugs Revenue by Country (2021-2026) & (USD Million)
Table 100. South America Monoclonal Antibodies Sterile Injectable Drugs Sales by Type (2016-2021e) & (K Units)
Table 101. South America Monoclonal Antibodies Sterile Injectable Drugs Sales by Type (2021-2026) & (K Units)
Table 102. South America Monoclonal Antibodies Sterile Injectable Drugs Sales by Application (2016-2021e) & (K Units)
Table 103. South America Monoclonal Antibodies Sterile Injectable Drugs Sales by Application (2021-2026) & (K Units)
Table 104. Middle East & Africa Monoclonal Antibodies Sterile Injectable Drugs Sales by Country (2016-2021e) & (K Units)
Table 105. Middle East & Africa Monoclonal Antibodies Sterile Injectable Drugs Sales by Country (2021-2026) & (K Units)
Table 106. Middle East & Africa Monoclonal Antibodies Sterile Injectable Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 107. Middle East & Africa Monoclonal Antibodies Sterile Injectable Drugs Revenue by Country (2021-2026) & (USD Million)
Table 108. Middle East & Africa Monoclonal Antibodies Sterile Injectable Drugs Sales by Type (2016-2021e) & (K Units)
Table 109. Middle East & Africa Monoclonal Antibodies Sterile Injectable Drugs Sales by Type (2021-2026) & (K Units)
Table 110. Middle East & Africa Monoclonal Antibodies Sterile Injectable Drugs Sales by Application (2016-2021e) & (K Units)
Table 111. Middle East & Africa Monoclonal Antibodies Sterile Injectable Drugs Sales by Application (2021-2026) & (K Units)
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Monoclonal Antibodies Sterile Injectable Drugs Typical Distributors
Table 115. Monoclonal Antibodies Sterile Injectable Drugs Typical Customers
List of Figures
Figure 1. Monoclonal Antibodies Sterile Injectable Drugs Picture
Figure 2. Global Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type in 2020
Figure 3. In Vivo Production Drugs
Figure 4. In Vitro Production Drugs
Figure 5. Global Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application in 2020
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Global Monoclonal Antibodies Sterile Injectable Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Monoclonal Antibodies Sterile Injectable Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Monoclonal Antibodies Sterile Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Monoclonal Antibodies Sterile Injectable Drugs Sales (2016-2026) & (K Units)
Figure 31. Global Monoclonal Antibodies Sterile Injectable Drugs Production Capacity (2016-2026) & (K Units)
Figure 32. Global Monoclonal Antibodies Sterile Injectable Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Monoclonal Antibodies Sterile Injectable Drugs Market Drivers
Figure 34. Monoclonal Antibodies Sterile Injectable Drugs Market Restraints
Figure 35. Monoclonal Antibodies Sterile Injectable Drugs Market Trends
Figure 36. Global Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Manufacturer in 2020
Figure 37. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Market Share by Manufacturer in 2020
Figure 38. Monoclonal Antibodies Sterile Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Monoclonal Antibodies Sterile Injectable Drugs Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Monoclonal Antibodies Sterile Injectable Drugs Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Region (2016-2026)
Figure 42. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Market Share by Region (2016-2026)
Figure 43. North America Monoclonal Antibodies Sterile Injectable Drugs Revenue (2016-2026) & (USD Million)
Figure 44. Europe Monoclonal Antibodies Sterile Injectable Drugs Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Monoclonal Antibodies Sterile Injectable Drugs Revenue (2016-2026) & (USD Million)
Figure 46. South America Monoclonal Antibodies Sterile Injectable Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Monoclonal Antibodies Sterile Injectable Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Global Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type (2016-2026)
Figure 49. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Market Share by Type (2016-2026)
Figure 50. Global Monoclonal Antibodies Sterile Injectable Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application (2016-2026)
Figure 52. Global Monoclonal Antibodies Sterile Injectable Drugs Revenue Market Share by Application (2016-2026)
Figure 53. Global Monoclonal Antibodies Sterile Injectable Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Country (2016-2026)
Figure 55. North America Monoclonal Antibodies Sterile Injectable Drugs Revenue Market Share by Country (2016-2026)
Figure 56. North America Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type (2016-2026)
Figure 57. North America Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application (2016-2026)
Figure 58. Europe Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Country (2016-2026)
Figure 59. Europe Monoclonal Antibodies Sterile Injectable Drugs Revenue Market Share by Country (2016-2026)
Figure 60. Europe Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type (2016-2026)
Figure 61. Europe Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Monoclonal Antibodies Sterile Injectable Drugs Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application (2016-2026)
Figure 66. South America Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Country (2016-2026)
Figure 67. South America Monoclonal Antibodies Sterile Injectable Drugs Revenue Market Share by Country (2016-2026)
Figure 68. South America Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type (2016-2026)
Figure 69. South America Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Monoclonal Antibodies Sterile Injectable Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Monoclonal Antibodies Sterile Injectable Drugs Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source

以下、関連資料のご紹介

世界の抗CD20モノクローナル抗体市場 2021：企業別、地域別、種類・用途別

Global Anti-CD20 Monoclonal Antibodies Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X01056 2021年5月 101Pages
当調査資料では、抗CD20モノクローナル抗体のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗CD20モノクローナル抗体の種類別市場規模（第1世代抗CD20モノクローナル抗体、第2世代抗CD20モノクローナル抗体、第3世代抗CD20モノクローナル抗体）...

世界の小分子抗体市場 2021：企業別、地域別、種類・用途別

Global Small Molecule Antibodies Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X18990 2021年5月 100Pages
当調査資料では、小分子抗体のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。小分子抗体の種類別市場規模（ウサギモノクローナル、その他）、用途別市場規模（小分子バイオマーカー検出、小分子薬バイオアベイラビリティ、食品安全・環境診断）、地域別市場規模（北米、...

世界の多発性骨髄腫治療薬市場 2021：企業別、地域別、種類・用途別

Global Multiple Myeloma Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X12183 2021年5月 98Pages
当調査資料では、多発性骨髄腫治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。多発性骨髄腫治療薬の種類別市場規模（化学療法、コルチコステロイド、免疫調節剤、モノクローナル抗体、ヒストンデアセチラーゼ（HDAC）阻害剤、プロテアソーム阻害剤、その他）...

世界の癌用二重特異性抗体市場 2021：企業別、地域別、種類・用途別

Global Bispecific Antibodies for Cancer Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X02586 2021年5月 108Pages
当調査資料では、癌用二重特異性抗体のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。癌用二重特異性抗体の種類別市場規模（CD19/CD3、CD30/CD16A）、用途別市場規模（病院、製薬企業、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界の滅菌医薬品有効成分市場 2021：企業別、地域別、種類・用途別

Global Sterile Active Pharmaceutical Ingredients Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X19751 2021年5月 101Pages
当調査資料では、滅菌医薬品有効成分のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。滅菌医薬品有効成分の種類別市場規模（水性、非水性液体、乾燥粉末、その他）、用途別市場規模（CNS、心臓血管、泌尿生殖器/ホルモン剤、呼吸器、リウマチ、糖尿病、腫瘍、その他...

世界の抗CD20モノクローナル抗体市場 2021：企業別、地域別、種類・用途別 The Anti-CD20 Monoclonal Antibodies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
モノクローナル抗体（mAb）バイオシミラーの世界市場予測 2023年：メーカー別、地域別、種類・用途別 A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…
全身性エリテマトーデス（SLE）薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces …
腎臓がんの薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Kidney cancer, also known as renal cancer, is a type of cancer that starts in the cells in the kidney. The two most common types of kidney cancer are renal cell carcinoma (RCC) and transitional cell carcinoma (TCC) of the renal pelvis. These names reflect the type of cell from which the cancer devel…
アトピー性皮膚炎薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Atopic dermatitis (AD) is a pruritic disease of unknown origin that usually starts in early infancy (an adult-onset variant is recognized). Scope of the Report: This report focuses on the Atopic Dermatitis Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, M…